Oxethazaine
Thông số
126-27-2Số CAS
204-780-5Số EC
2-[2-hydroxyethyl-[2-[methyl-(2-methyl-1-phenylpropan-2-yl)amino]-2-oxoethyl]amino]-N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamideTên IUPAC
C28H41N3O3Công thức hóa học
467.6 g/molKhối lượng phân tử
Oxethazaine; 126-27-2; Oxetacaine; Oxethacaine; Oxaine; Muthesa; Strocain; Oxetacaina; oxethazine; Oxetacainum; Wy-806; WY 806; DTXSID0025818; Acetamide, 2,2'-((2-hydroxyethyl)imino)bis(N-(1,1-dimethyl-2-phenylethyl)-N-methyl-; FH 099; NSC-758444; Acetamide, 2,2'-[(2-hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methyl-; IP8QT76V17; DTXCID605818; 2-Di(N-methyl-N-phenyl-tert-butyl-carbamoylmethyl)aminoethanol; N,N-Bis(N-methyl-N-phenyl-tert-butylacetamido)-beta-hydroxyethylamine; 2,2'-((2-Hydroxyethyl)imino)bis(N-(alpha,alpha-dimethylphenethyl)-N-methylacetamide); Acetamide, 2,2'-((2-hydroxyethyl)imino)bis(N-(alpha,alpha-dimethylphenethyl)-N-methyl-; N-(1,1-dimethyl-2-phenyl-ethyl)-2-[[2-[(1,1-dimethyl-2-phenyl-ethyl)-methyl-amino]-2-oxo-ethyl]-(2-hydroxyethyl)amino]-N-methyl-acetamide; N-(1,1-dimethyl-2-phenyl-ethyl)-2-((2-((1,1-dimethyl-2-phenyl-ethyl)-methyl-amino)-2-oxo-ethyl)-(2-hydroxyethyl)amino)-N-methyl-acetamide; RefChem:857129; C05AD06; 2,2'-((2-hydroxyethyl)imino)bis(N-alpha,alpha-dimethylphenethyl)-N-methylacetamide; 2,2'-(2-Hydroxyethylimino)bis(N-(1,1-dimethyl-2-phenylethyl)-N-methylacetamide); 204-780-5; oxetacain; Mucaine; Betalgil; Oxaethacainum; Oxetacaine [INN]; CHEMBL127592; 2-[2-hydroxyethyl-[2-[methyl-(2-methyl-1-phenylpropan-2-yl)amino]-2-oxoethyl]amino]-N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide; Oxetacaine (INN); MFCD00079202; NCGC00016382-01; CAS-126-27-2; 2,2'-((2-Hydroxyethyl)imino)bis(N-(1,1-dimethyl-2-phenylethyl)-N-methylacetamide); C28H41N3O3; Oxethacaina [Italian]; Milzine; Oxetacainum [INN-Latin]; Oxetacaina [INN-Spanish]; 2,2'-[(2-Hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methylacetamide]; CCRIS 4692; SR-05000001851; EINECS 204-780-5; Oxethazaine [USAN:JAN]; BRN 2404063; UNII-IP8QT76V17; Prestwick_767; Oxethazaine (Standard); Spectrum_001657; OXETHAZAINE [MI]; Prestwick0_000058; Prestwick1_000058; Prestwick2_000058; Prestwick3_000058; Spectrum2_001987; Spectrum3_001751; Spectrum4_000202; Spectrum5_001269; OXETHAZAINE [JAN]; OXETHAZAINE [USAN]; cid_4621; OXETACAINE [MART.]; OXETACAINE [WHO-DD]; Oxethazaine (JP18/USAN); SCHEMBL24489; BSPBio_000215; BSPBio_003482; KBioGR_000803; KBioSS_002137; 4-12-00-02822 (Beilstein Handbook Reference); MLS002154188; DivK1c_000715; SPECTRUM1503279; SPBio_002136; SPBio_002173; BPBio1_000237; orb1226646; orb1310992; Oxethazaine, analytical standard; CHEBI:31947; HMS502D17; HY-B0955R; KBio1_000715; KBio2_002137; KBio2_004705; KBio2_007273; KBio3_002702; NINDS_000715; HMS1568K17; HMS1922A04; HMS2093C15; HMS2095K17; HMS2236A03; HMS3370M13; HMS3712K17; HMS3885P21; HMS5083A13; Pharmakon1600-01503279; HY-B0955; MSK10514; Tox21_110407; BDBM50017672; CCG-39525; EBC-27170; NSC758444; AKOS024284189; Tox21_110407_1; CS-4432; DB12532; FO26625; NSC 758444; IDI1_000715; NCGC00016382-02; NCGC00016382-03; NCGC00016382-04; NCGC00016382-07; NCGC00016382-09; NCGC00095039-01; NCGC00095039-02; NCGC00095039-03; 2-[(2-hydroxyethyl)({[methyl(2-methyl-1-phenylpropan-2-yl)carbamoyl]methyl})amino]-N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide; MS-28631; SMR001233479; ST073363; SY491470; SBI-0051816.P002; DB-041818; AB00052348; NS00010381; SW196906-3; T0044; D01152; G12282; AB00052348_08; AB00052348_09; EN300-26506802; Q2412605; SR-05000001851-1; SR-05000001851-3; BRD-K56940463-001-05-4; BRD-K56940463-001-08-8; BRD-K56940463-001-13-8; BRD-K56940463-001-14-6; 2-Di(N-methyl-N-phenyl-tert-butyl-carbamoylmethyl)amino ethanol; 2,2'-[(2-Hydroxyethyl)azanediyl]bis[N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide]; 2,2 inverted exclamation marka-[(2-Hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methylacetamide]; 2,2'-((2-HYDROXYETHYL)IMINO)BIS(N-(.ALPHA.,.ALPHA.-DIMETHYLPHENETHYL)-N-METHYLACETAMIDE); N-(1,1-Dimethyl-2-phenyl-ethyl)-2-[{[(1,1-dimethyl-2-phenyl-ethyl)-methyl-carbamoyl]-methyl}-(2-hydroxy-ethyl)-amino]-N-methyl-acetamide; N-(1,1-dimethyl-2-phenylethyl)-2-({[N-(1,1-dimethyl-2-phenylethyl)-N-methylcar bamoyl]methyl}(2-hydroxyethyl)amino)-N-methylacetamide; Oxetacain (Oxethazin)Tên gọi khác
Sản phẩm chứa Oxethazaine
위그린정가스트릴정일양쓰리쏙정툴스속편정넥시겔현탁액(수출명: Nexigel suspension)(수출용)바루돈현탁액(수출용)알미틴플러스정위모닝정노시드정트립겔현탁액(수출용)포세라정프리번정
Trang 1/4
Công ty đang bán Oxethazaine
CT
Công ty TNHH BRV HealthcareViet Nam한림
한림제약(주)Republic of Korea(주
(주)테라젠이텍스Republic of Korea일양
일양약품(주)Republic of Korea(주
(주)넥스팜코리아Republic of Korea영진
영진약품(주)Republic of Korea메딕
메딕스제약(주)Republic of KoreaDP
Daewon Pharmaceutical Co., Ltd.Republic of KoreaTrang 1/3